| Authors | Darab Mehraban, Fatemeh Esfahani |
| Journal | The Journal of urology
(J Urol)
Vol. 174
Issue 3
Pg. 1151; author reply 1151
(Sep 2005)
ISSN: 0022-5347 [Print] United States |
| PMID | 16094088
(Publication Type: Comment, Comparative Study, Letter)
|
| Chemical References |
- Adjuvants, Immunologic
- Antibiotics, Antineoplastic
- BCG Vaccine
- Epirubicin
|
| Topics |
- Adjuvants, Immunologic
(administration & dosage, adverse effects)
- Antibiotics, Antineoplastic
(administration & dosage, adverse effects)
- BCG Vaccine
(administration & dosage, adverse effects)
- Carcinoma in Situ
(drug therapy, pathology)
- Clinical Trials, Phase III as Topic
(statistics & numerical data)
- Epirubicin
(administration & dosage, adverse effects)
- Humans
- Mathematical Computing
- Multicenter Studies as Topic
- Neoplasms, Multiple Primary
(drug therapy, pathology)
- Neoplasms, Second Primary
(drug therapy, pathology)
- Randomized Controlled Trials as Topic
(statistics & numerical data)
- Reproducibility of Results
- Sample Size
- Urinary Bladder Neoplasms
(drug therapy, pathology)
|
